Clinical Trial Update: Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy of combining Reboxetine and Methylphenidate for attentional, sensory, and emotional dysregulation in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)
• Reboxetine (Reboxetine)

Snippet

Sponsor: University of Haifa | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: RECRUITING